Skip to main content

Table 1 Patient demographics and outcomes

From: Reducing anastomotic leakage in TaTME by mucosal coverage of staple lines: a pilot study with preliminary results

Median age, years (range)

68.0 (46–83)

Sex (male/female)

(36/15)

Median distance from anal verge, cm (range)

5.43(3–11)

 Neoadjuvant therapy

22 (43.1%)

  Chemoradiotherapy

18

  Chemotherapy

2

  Total neoadjuvant therapy

2

Diversion ileostomy or colostomy (%)

46 (90.2)

Lateral pelvic lymph node dissection (%)

11 (21.6)

Total operative time, min (range)

283.1 (144–439)

Estimated blood loss, mL (range)

84.6 (10–450)

Distal margin, cm (range)

2.2 (0.5–5.7)

Postoperative complication (%)

3 (5.9)

 Clavien-Dindo ≥ 3

0

 Anastomotic leakage

0

Mortality

0

Recurrence (Stage I-III) (%)

2 (4.1%)